eTheRNA
Total Funding
$39 Million
Total Rounds
1
First Raise
Aug 27, 2022
Latest Raise
Aug 27, 2022
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
All Funding Rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 8/27/2022 | Series B2 | €39 Million | Novalis LifeSciences |
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics